Semax | Luxbae Peptide Therapy

Home › Peptides › Semax
ACTH (4-10) Analogue

Semax Russian Nootropic

The synthetic ACTH (4-10) heptapeptide developed in Russia for stroke, anxiety, and cognitive support.

Book Free ConsultationCall 310.299.4444

What Semax actually is

Semax is a synthetic heptapeptide based on residues 4-10 of ACTH (adrenocorticotropic hormone), with a Pro-Gly-Pro C-terminal extension that resists peptidase degradation. It was developed at the Institute of Molecular Genetics in Moscow and is approved in Russia for ischemic stroke and other neurological conditions.1

Semax has been shown to upregulate BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) expression, modulate monoaminergic systems, and exert antioxidant effects in CNS tissue.2 Russian clinical trials in stroke and cognitive deficits report functional improvements.3

At Luxbae, Semax is prescribed and supervised by Dr. Ernst von Schwarz, MD, PhD after a complimentary medical consultation.

Mechanism — BDNF and NGF upregulation

Increases expression of brain-derived neurotrophic factor and nerve growth factor; modulates dopaminergic and serotonergic signaling.2

What the research shows

BDNF/NGF expression. Documented upregulation in animal and human CNS tissue.2

Cognitive support. Improvements in attention, memory, and processing speed in Russian clinical literature.3

Stroke recovery. Approved in Russia for ischemic stroke management.

Side effects: Generally well-tolerated. Mild nasal irritation, occasional headache, rare hyperactivity.

FDA note: Not FDA-approved. Approved in Russia for ischemic stroke and related conditions. Prescribed at Luxbae as investigational under medical supervision.

Semax FAQ

Is this safe?
Long Russian clinical experience — generally well-tolerated.

Will I notice immediately?
Some patients report next-day mood/clarity changes; cognitive effects layer over weeks.

References

  1. Kaplan AYa, Kochetova AG, Nezavibathko VN, et al. Synthetic ACTH analogue Semax displays nootropic-like activity in humans. Neurosci Res Commun. 1996.
  2. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of adrenocorticotropin (4-10), binds specifically and increases the level of BDNF. Brain Res. 2006.
  3. Gusev EI, Skvortsova VI, Miasoedov NF, et al. Effectiveness of semax in acute period of hemispheric ischemic stroke. Zh Nevrol Psikhiatr. 1997.

Start your Semax protocol at Luxbae

Call 310.299.4444Book Online
Medical disclaimer: This is educational information, not medical advice. Semax is investigational and many uses are not FDA-approved; treatments at Luxbae are administered under medical supervision by Dr. Ernst von Schwarz. Individual results vary.
Scroll to Top